|
Wednesday 12th October 2022 |
Text too small? |
Rua Bioscience (NZX: RUA ) advises that all resolutions put to its hybrid Annual Shareholders’ Meeting (held online and in Gisborne today) were passed by Shareholders.
Those resolutions being:
- That the Board be authorised to fix the auditor’s remuneration.
- That Trevor Burt be re-elected as a director of Rua.
- That Brett Gamble be re-elected as a director of Rua.
- That Teresa Ciprian be re-elected as a director of Rua.
The results of the voting poll are in the attached document.
Ends
For more information, please visit www.ruabio.com or contact:
Media
Kerry Donovan
Communications Manager
+64 (21) 128 7689
kerry.donovan@ruabio.com
Investors
Hamish White
Chief Financial Officer
+64 (21) 050 5795
Hamish.white@ruabio.com
Rua Bioscience Results of the 2022 Annual Shareholders' Meeting
No comments yet
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update
Genesis Energy Limited - Strategy & Earnings Growth On Trac